Chinmo defines the region-specific oncogenic competence in the <i>Drosophila</i> central nervous system

P Phuong-Khanh Nguyen (Sir Peter MacCallum Department of Oncology, The University of Melbourne) F Francesca Froldi (Sir Peter MacCallum Department of Oncology, The University of Melbourne) J John P. D. McMullen (Menzies Institute for Medical Research, University of Tasmania) T Tony D. Southall (Department of Life Sciences, Imperial College London) O Owen J. Marshall (Menzies Institute for Medical Research, University of Tasmania) L Louise Y. Cheng (Sir Peter MacCallum Department of Oncology, The University of Melbourne)

Abstract

While genetic mutations can promote hyperplastic growth, they do not always result in oncogenic outcomes. We and others have previously identified the transcription factors Nerfin-1 and Lola as inhibitors of dedifferentiation. Here, we investigate how the oncogenic potential of dedifferentiation varies across different neural lineages in the Drosophila central nervous system. We found that Nerfin-1 inactivation causes tumorigenic phenotypes in the central brain and the ventral nerve cord but not the optic lobes (OLs). In contrast, Lola inactivation leads to tumor overgrowth specifically in the OLs. We identify Chinmo, a temporal transcription factor, and its regulation by ecdysone signaling as key determinants of the oncogenic competence in different regions of the brain, influencing the tumorigenic outcome of dedifferentiation. This study provides a fundamental framework to understand how oncogenic competence arises beyond genetic mutations.

Article Details

Volume / Issue Vol. 123, Issue 21
Published May 26, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (6)

P

Phuong-Khanh Nguyen

Sir Peter MacCallum Department of Oncology, The University of Melbourne

F

Francesca Froldi

Sir Peter MacCallum Department of Oncology, The University of Melbourne

J

John P. D. McMullen

Menzies Institute for Medical Research, University of Tasmania

T

Tony D. Southall

Department of Life Sciences, Imperial College London

O

Owen J. Marshall

Menzies Institute for Medical Research, University of Tasmania

L

Louise Y. Cheng

Sir Peter MacCallum Department of Oncology, The University of Melbourne